indolent systemic mastocytosis

無痛性全身性マスト細胞症、無痛性全身性肥満細胞症

関

aggressive systemic mastocytosis、systemic mast-cell disease、systemic mastocytosis

WordNet

1. (physical chemistry) a sample of matter in which substances in different phases are in equilibrium; "in a static system oil cannot be replaced by water on a surface"; "a system generating hydrogen peroxide"
2. instrumentality that combines interrelated interacting artifacts designed to work as a coherent entity; "he bought a new stereo system"; "the system consists of a motor and a small computer"
3. a group of independent but interrelated elements comprising a unified whole; "a vast system of production and distribution and consumption keep the country going" (同)scheme
4. a complex of methods or rules governing behavior; "they have to operate under a system they oppose"; "that language has a complex system for indicating gender" (同)system of rules
5. a group of physiologically or anatomically related organs or parts; "the body has a system of organs for digestion"
6. a procedure or process for obtaining an objective; "they had to devise a system that did not depend on cooperation"
7. the living body considered as made up of interdependent components forming a unified whole; "exercise helped him get the alcohol out of his system"
8. affecting an entire system; "a systemic poison"
9. (of tumors, e.g.) slow to heal or develop and usually painless; "an indolent ulcer"; "leprosy is an indolent infectious disease"

PrepTutorEJDIC

1. 〈C〉(関連した部分から成る)『体系』,系統,組織[網],装置 / 〈C〉(教育・政治などの)『制度』,機構;《the~》体制 / 〈C〉(思想・学問などの)『体系』,学説 / 〈C〉(…の)『方法』,方式,やり方《+of doing》 / 〈U〉正しい方針(筋道,順序) / 〈U〉《the~》(身体の)組織,系統 / 〈U〉《the~,one's~》身体,全身
2. (身体・言語のように)体系の,組織の / 全身の,全身的
3. 無精な,怠惰な

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 全身性肥満細胞症の治療および予後 treatment and prognosis of systemic mastocytosis
• 2. Systemic mastocytosis: Determining the category of disease
• 3. 肥満細胞症（皮膚および全身性）：疫学、病因、および臨床症状 mastocytosis cutaneous and systemic epidemiology pathogenesis and clinical manifestations
• 4. Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in adults
• 5. Mastocytosis (cutaneous and systemic): Evaluation and diagnosis in children

English Journal

• Smouldering systemic mastocytosis with lymph node involvement mimicking malignant lymphoma.

• Xu Z1, Jamison B, Bence-Bruckler I.
• Annals of hematology.Ann Hematol.2014 Sep;93(9):1603-4. doi: 10.1007/s00277-013-1993-9. Epub 2013 Dec 15.
• PMID 24337517

• Refined diagnostic criteria and classification of mast cell leukemia (MCL) and myelomastocytic leukemia (MML): a consensus proposal.

• Valent P1, Sotlar K2, Sperr WR3, Escribano L4, Yavuz S5, Reiter A6, George TI7, Kluin-Nelemans HC8, Hermine O9, Butterfield JH10, Hägglund H11, Ustun C12, Hornick JL13, Triggiani M14, Radia D15, Akin C16, Hartmann K17, Gotlib J18, Schwartz LB19, Verstovsek S20, Orfao A4, Metcalfe DD21, Arock M22, Horny HP2.
• Annals of oncology : official journal of the European Society for Medical Oncology / ESMO.Ann Oncol.2014 Sep;25(9):1691-1700. Epub 2014 Mar 27.
• Mast cell leukemia (MCL), the leukemic manifestation of systemic mastocytosis (SM), is characterized by leukemic expansion of immature mast cells (MCs) in the bone marrow (BM) and other internal organs; and a poor prognosis. In a subset of patients, circulating MCs are detectable. A major differenti
• PMID 24675021

• The presence of mast cell clonality in patients with unexplained anaphylaxis.

• Gülen T1, Hägglund H, Sander B, Dahlén B, Nilsson G.
• Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.Clin Exp Allergy.2014 Sep;44(9):1179-87. doi: 10.1111/cea.12369.
• BACKGROUND: The mechanisms by which mast cells in patients with unexplained anaphylaxis (UEA) are triggered remain elusive. Onset of episodes is unpredictable and often recurrent. The substantial overlap between the clinical manifestations of UEA and clonal mast cell disorders (CMD) suggests an asso
• PMID 25039926

Related Links

• Mastocytosis - Wikipedia, the free encyclopedia

Telangiectasia macularis eruptiva perstans (TMEP) is a much rarer form of cutaneous mastocytosis that affects adults. UP and TMEP can evolve into indolent systemic mastocytosis. This should be considered if patients develop any systemic ...

---

★リンクテーブル★

リンク元	「無痛性全身性肥満細胞症」「aggressive systemic mastocytosis」「無痛性全身性マスト細胞症」
関連記事	「systemic」「system」「indolent」

「無痛性全身性肥満細胞症」

　　[★]

英

indolent systemic mastocytosis

関

全身性肥満細胞症、侵襲性全身性肥満細胞症、全身性マスト細胞疾患、無痛性全身性マスト細胞症

「aggressive systemic mastocytosis」

　　[★]

侵襲性全身性肥満細胞症

関

indolent systemic mastocytosis、systemic mast-cell disease、systemic mastocytosis

「無痛性全身性マスト細胞症」

　　[★]

英

indolent systemic mastocytosis

関

無痛性全身性肥満細胞症

「systemic」

　　[★]

• adj.

• 全身性の、全身的な、全身の、(植物)浸透移行性の

関

general、generalized、systemically、total body、whole body、whole-body

　 　

「system」

　　[★]

• n.

• 系、システム、体系、体制、方式

関

method、series、strain

　 　 　 　 　 　 　 　

「indolent」

　　[★]

• adj.

• 低悪性度の, 緩徐進行型の

関

agressive